Insider transaction 📈 Stocks 🌍 United States

Hims & Hers CLO Soleil Boughton Sells 6,236 Shares Under Trading Plan

CLO Soleil Boughton offloaded 6,236 shares of Hims & Hers Health, though the executive maintains a significant stake of over 300,000 shares following the pre-planned sale.

📅 September 19, 2026 🕐 1 min read

1 assets impacted (Stocks). Net bias: 0 Bullish, 0 Bearish, 1 Neutral. Strongest signal: HIMS → 1/10 (62% confidence).

📊 Affected Assets (1)

HIMS

Neutral 🤖 62%

📅 Short-term 🌍 US · Explicit

Chief Legal Officer sold 6,236 shares under a Rule 10b5-1 trading plan, but retains over 300,000 shares, indicating the sale is pre-planned and not a signal of distress.

🎯 Key Takeaways

The sale of 6,236 shares was conducted via a Rule 10b5-1 plan adopted in May 2026, indicating a pre-scheduled transaction.
Boughton retains a substantial direct equity interest of 304,270 shares, valued at approximately $8.5 million.
Despite a 51.5% decline in share price over the past year, the transaction is classified as routine portfolio management.

📝 Executive Summary

Hims & Hers Health Chief Legal Officer Soleil Boughton sold 6,236 shares of company stock in a transaction valued at approximately $173,735. The sale was executed under a pre-established Rule 10b5-1 trading plan, signaling a routine divestment rather than a shift in corporate outlook.

❓ FAQ

Does the CLO's share sale indicate internal distress at Hims & Hers?

No. The sale was executed under a Rule 10b5-1 trading plan established in May 2026, which is a standard mechanism for insiders to sell shares without triggering concerns regarding non-public information.

📰 Related Articles

🏷️ Tags

📰 Source

🔗 View Original Article